BioArctic AB (publ) (BRCTF)
OTCMKTS · Delayed Price · Currency is USD
33.14
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of $3.17 billion as of February 12, 2026. Its market cap has increased by 79.87% in one year.
Market Cap
3.17B
Enterprise Value
2.96B
Revenue
203.37M
Ranking
n/a
PE Ratio
29.89
Stock Price
$33.14
Market Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 315.33M to 3.17B, an increase of 905.56%. That is a compound annual growth rate of 31.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.17B | 5.79% |
| Dec 30, 2025 | 3.00B | 87.75% |
| Dec 30, 2024 | 1.60B | -31.92% |
| Dec 29, 2023 | 2.35B | 1.97% |
| Dec 30, 2022 | 2.30B | 98.17% |
| Dec 30, 2021 | 1.16B | 13.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |